Ren in Pharmaceutical Companies
June 26, 2019

The Connection between the FDA, Pharmaceutical Companies, and Addiction

One of the most common questions I hear regarding addiction is, “How did the addiction epidemic get so bad?” And I can see why people ask this.


Despite Epidemic, the FDA Approves a Powerful New Pain Killer

Jake Harper of reported on Nov. 2, 2018 that the FDA has approved the distribution of Dsuvia, a very potent opioid pain reliever. It is 5 to 10 times more potent than fentanyl and 1,000 more potent than morphine.


Pharmaceutical Distributors Next in Line for Congressional Investigation

Families who have lost loved ones to the opioid epidemic should be pleased that five chairmen of pharmaceutical distribution companies have been called before Congress to account for their actions. These executives could be required to fund the recovery of millions of Americans, depending on the findings of Congress.